Discover how estrogen leverages the AT1 receptor to drive endometrial cancer cell growth and the potential therapeutic implications.
Explore how neoadjuvant intra-arterial infusion chemotherapy influences apoptosis and multidrug resistance in endometrial cancer through targeted molecular mechanisms.
Discover how N6-methyladenosine (m6A) RNA modifications and YTHDF2 protein drive endometrioid endometrial carcinoma progression through FENDRR degradation.